Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Agouron and Roche sign codevelopment agreement

June 28, 1996

Lu-Tex deemed safe and effective in phase I trial

June 21, 1996

TH-9402 covered under U.S. patent

June 21, 1996

Encouraging preclinical results for G-3139

June 21, 1996

Onyx and Lilly expand BRCA1 research agreement

June 21, 1996

Universidad de Salamanca reveals LL-15

June 21, 1996

Breast/prostate cancer treatment agents reported

June 21, 1996

Development of DS-4152 for Kaposi's sarcoma in AIDS patients terminated

June 21, 1996

Potential cancer/nephritis derivatives reported

June 21, 1996

Positive preclinical results for Onconase reported

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...